Clay Thorp, Director, 10% Owner at Clearside Biomedical, Inc. (CLSD), sold 50,000 shares at $8.64 ($430K) on 2017-10-03, disclosed to the SEC on 2017-10-05.
Open-market sale of $430k CLSD by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.64 | 15,000 | $130K | 30.2% |
| 2 | $8.64 | 15,000 | $130K | 30.2% |
| 3 | $8.59 | 14,000 | $120K | 28.0% |
| 4 | $8.34 | 6,000 | $50K | 11.7% |
| Total | $8.59 avg | 50,000 | $430K | 100% |
| Filing → |
| CLSD | BUY | 2022-12-21 | $14K | — | Filing → |
| VIGL | BUY | 2022-05-17 | $165K | — | Filing → |
| VIGL | BUY | 2022-03-28 | $22K | — | Filing → |